Leadsynbio

Leadsynbio, founded in 2015, is a pioneering bio-manufacturing technology company that is making significant strides in the sustainable production of chemical products. The company's slogan "Advancing sustainable bio-manufacturing with innovative enzyme engineering and metabolic solutions" encapsulates its commitment to environmental responsibility and technological advancement. With a focus on biopharma, biotechnology, health care, and manufacturing industries, Leadsynbio is at the forefront of creating eco-friendly solutions and reducing pollution in heavy industries. Leadsynbio's core expertise lies in bio-catalytic synthesis processes, enzyme product development, and comprehensive production, sales, and technical services. The company also extends its support to downstream businesses through services such as enzyme engineering, strain modification, and metabolic engineering, offering outsourced technical and production expertise. In a significant development, Leadsynbio secured a Series D investment of $20.91M on 11 August 2023, with funding from prominent investors including Lilly Asia Ventures and Sherpa Venture Capital. This substantial investment attests to the confidence that industry leaders have in Leadsynbio's vision and potential for growth and impact in the bio-manufacturing sector. With this latest injection of capital, Leadsynbio is well-positioned to further advance its cutting-edge technologies and expand its reach in creating sustainable solutions for the industries it serves.